- Investing Ideas
- /
- Swedish Undervalued Stocks Based On Cash Flows
Swedish Undervalued Stocks Based On Cash Flows
Results
43
10 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
43 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NWG | SEK 175.00 | -0.2% | 7.1% | SEK 4.2b | SEK 168.25 | PE20.9x | E23.6% | 2.9% | Capital Goods | ||
TFBANK | SEK 319.00 | -1.5% | 120.6% | SEK 6.9b | SEK 355.00 | PB2.7x | E29.7% | n/a | Banks | ||
VERT B New | SEK 58.40 | 5.8% | 174.2% | SEK 1.3b | SEK 61.00 | PE38x | E44.4% | 0% | Software | ||
NREST New | SEK 109.80 | 0.2% | n/a | SEK 1.4b | SEK 155.00 | PE12.3x | E20.2% | n/a | Consumer Services | ||
SVED B | SEK 42.30 | -6.4% | 32.6% | SEK 2.2b | SEK 53.50 | PE17.5x | E23.0% | 2.4% | Capital Goods | ||
SVED BTA B | SEK 36.30 | 2.8% | n/a | SEK 1.9b | n/a | PE13.8x | E24.9% | n/a | Capital Goods | ||
XVIVO New | SEK 447.00 | -1.3% | 68.0% | SEK 14.1b | SEK 538.17 | PE68.9x | E24.6% | n/a | Healthcare | ||
NETI B New | SEK 6.72 | -0.4% | 44.6% | SEK 2.3b | SEK 8.25 | PE27.4x | E22.5% | n/a | Tech | ||
BACTI B | SEK 33.70 | -6.1% | -44.3% | SEK 1.2b | SEK 55.00 | PS5x | E100.0% | n/a | Healthcare | ||
NORVA New | SEK 26.05 | -16.6% | 8.5% | SEK 4.8b | SEK 35.40 | PE24.5x | E21.2% | n/a | Commercial Services | ||
IAR B | SEK 127.00 | 0.4% | 14.0% | SEK 1.7b | SEK 200.00 | PS3.2x | E63.5% | 1.2% | Software | ||
AVEN | SEK 7.76 | 3.7% | -12.8% | SEK 288.1m | SEK 14.00 | PE17.5x | E22.9% | 0% | Software | ||
SINCH | SEK 19.73 | -12.7% | -27.3% | SEK 16.7b | SEK 35.19 | PS0.6x | E111.8% | n/a | Software | ||
FAG | SEK 58.20 | -4.6% | -5.1% | SEK 10.3b | SEK 72.00 | PE25.1x | E24.4% | 3.1% | Capital Goods | ||
FLEXM | SEK 7.90 | 4.5% | -15.8% | SEK 444.9m | SEK 20.13 | PS0.4x | E103.9% | n/a | Media | ||
BHG | SEK 16.85 | -8.4% | 30.3% | SEK 3.0b | SEK 20.50 | PS0.3x | E113.4% | n/a | Retail | ||
SWEC B | SEK 158.60 | -5.8% | 32.4% | SEK 57.0b | SEK 193.60 | PE30.2x | E15.6% | 1.9% | Capital Goods | ||
FG | SEK 40.70 | 3.0% | -22.5% | SEK 2.0b | SEK 83.50 | PE16.3x | E64.3% | 4.2% | Capital Goods | ||
GENI | SEK 47.30 | 12.6% | -5.0% | SEK 581.4m | n/a | PE24.6x | E19.8% | 3.2% | Software | ||
MAVEN | SEK 10.85 | -3.6% | -7.3% | SEK 571.0m | SEK 13.00 | PE31.7x | E31.8% | 0.9% | Tech | ||
EPRO B | SEK 63.20 | -9.1% | 38.2% | SEK 18.2b | SEK 77.67 | PE24x | E20.3% | 1.3% | Capital Goods | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | Healthcare | ||
CEVI | SEK 211.50 | -11.5% | 22.8% | SEK 5.0b | SEK 270.00 | PE33.6x | E22.8% | 1.1% | Healthcare | ||
HMS | SEK 371.40 | -3.8% | -15.9% | SEK 18.6b | SEK 457.50 | PE53.9x | E42.5% | 1.2% | Tech |